Related Experiment Video
Updated: Feb 16, 2026

Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
α-synuclein Induces Mitochondrial Dysfunction through Spectrin and the Actin Cytoskeleton.
Dalila G Ordonez1, Michael K Lee2, Mel B Feany3
1Department of Molecular and Cellular Biology, Harvard University, Cambridge, MA 02138, USA; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Parkinson's disease involves alpha-synuclein (α-synuclein) aggregation. This study reveals α-synuclein disrupts the actin cytoskeleton, leading to mitochondrial dysfunction and neurotoxicity, offering new therapeutic targets.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Alpha-synuclein (α-synuclein) aggregation and neurotoxicity are central to Parkinson's disease (PD) and related synucleinopathies.
- Understanding the molecular mechanisms driving α-synuclein-induced neurodegeneration is crucial for developing effective therapies.
Purpose of the Study:
- To establish and characterize a novel Drosophila melanogaster model for studying α-synucleinopathies.
- To elucidate the molecular pathways linking α-synuclein expression to neurodegeneration and mitochondrial dysfunction.
Main Methods:
- Generated a Drosophila model expressing wild-type human α-synuclein.
- Conducted forward genetic screening and genetic analysis.
- Investigated actin cytoskeleton dynamics, mitochondrial function, and protein interactions.
Main Results:
- The Drosophila model exhibited significant neurodegeneration, locomotor deficits, and α-synuclein aggregation.
- α-synuclein expression induced actin network reorganization and mitochondrial dysfunction via altered Drp1 localization.
- Similar cytoskeletal and mitochondrial changes were observed in a mouse model and human patient tissues.
- Demonstrated that α-synuclein interaction with spectrin initiates actin cytoskeleton pathology and neurotoxicity.
Conclusions:
- The novel Drosophila model effectively recapitulates key features of α-synucleinopathies.
- α-synuclein-induced neurotoxicity is mediated by disruption of the actin cytoskeleton and subsequent mitochondrial dysfunction.
- Targeting the α-synuclein-spectrin interaction and actin cytoskeleton may offer novel therapeutic strategies for synucleinopathies.
Related Concept Videos
ATP Synthase: Mechanism
The Inner Mitochondrial Membrane
Mitochondrial Membranes
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Mitochondria

